Skip to the answer
An orange marker beside a forked path made from paper strips on a white tabletop

Pause points

A polished offer can still rest on a missing product

A logo, intake form, or prescription does not answer what is actually in the package.

Cagrilintide status checked: September 2026.

Stop at a research-only vial

The FDA has cited sellers that paired cagrilintide claims with labels such as “for research only.” It treated the products as unapproved drugs marketed for human use.

Stop if the prescription is the whole explanation

A prescription cannot create an approved product. The FDA says pharmacies may not make cagrilintide for patients.

Stop if nobody names the source

Ask which company made the product, which pharmacy sends it, and where the product appears in an FDA record. “FDA registered” does not mean “FDA approved.”

Stop if the intake cannot respond to you

A static web questionnaire that leaves no room for follow-up questions does not meet the recommended telehealth standard published by a national group of state medical boards.

Chapter recap

Do five separate checks: the exact product, its maker, the clinician, the pharmacy, and the matching public record.

Chapter notes

See the full endnote desk